.jpg?format=webp&width=780)
The study highlighted a critical development in treating heart attack patients with cardiogenic shock. Studies showed that the 30-day mortality rate has historically approached 50% among such patients. However, modern clinical trials and registries have revealed promising outcomes using extracorporeal life support (ECLS) using venoarterial extracorporeal membrane oxygenation. ECLS not only enhances overall circulatory support but also effectively manages respiratory failure.
Like
Save
Share